How long until I feel something on a peptide cycle?
Depends on the peptide. Recovery peptides: 2–4 weeks. GH secretagogues: 1–3 weeks for sleep, 8+ weeks for body comp. IGF-1 LR3: faster but quieter.
Updated May 8, 2026 · 5 min read
It depends on the peptide. Recovery peptides like BPC-157 and TB-500 take 2–4 weeks to start changing pain or mobility. GH secretagogues (Sermorelin, Ipamorelin, CJC-1295) often produce sleep changes in 1–3 weeks but body composition takes 8+ weeks. IGF-1 LR3 acts faster but with less subjective "feel." The category that almost never produces an acute on-injection sensation is the recovery peptides — that lack of immediate signal isn't a quality problem, it's the mechanism.
Reference table — typical onset by peptide
| Peptide | First subjective sign | What you'll notice | Full effect |
|---|---|---|---|
| BPC-157 | 2–4 weeks | Reduced soreness, target injury feels less reactive | 6–12 weeks |
| TB-500 | 1–2 weeks (loading phase) | Mild lethargy, then whole-body recovery shift | 4–8 weeks |
| Sermorelin | 1–2 weeks | Deeper sleep, vivid dreams | 8–12 weeks for body comp |
| Ipamorelin | 1–2 weeks | Sleep depth, mild morning hunger | 8–12 weeks for body comp |
| CJC-1295 (no DAC) | 1–3 weeks | Sleep, mild appetite shift | 8–12 weeks for body comp |
| CJC-1295 with DAC | 1–3 weeks | Sustained mild GH effects | 8–12 weeks |
| MK-677 | 3–7 days | Appetite spike, water retention, sleep changes | 6–12 weeks |
| IGF-1 LR3 | 3–14 days | Pump, fullness, occasional hypoglycemia signs | 4–8 weeks |
| Tesamorelin | 2–4 weeks | Body comp shift (visceral fat focus) | 12–24 weeks |
| MOTS-c | 2–4 weeks | Energy, exercise tolerance | 4–8 weeks |
| GHK-Cu | 2–6 weeks (topical/SubQ) | Skin texture, recovery | 8–12 weeks |
These are rough patterns from self-experimentation reports, not guarantees. Individual response varies.
Why recovery peptides feel "quiet"
BPC-157 and TB-500 are tissue-level repair compounds. They don't bind a single receptor that produces an immediate sensation. The mechanism is angiogenesis, growth-factor upregulation, and cellular migration — all processes that take days to weeks to manifest as reduced pain or improved mobility. There is no acute "I felt that injection" moment for either compound. If you're judging at week one, you're judging too early.
For BPC-157 specifically, see how long does BPC-157 take to work?.
Why GH secretagogues split into "fast" and "slow" effects
Secretagogues produce two different timelines:
| Effect | Timeline | Why |
|---|---|---|
| Sleep depth, dreams | 1–3 weeks | Direct GH pulse during sleep |
| Recovery, soreness | 2–4 weeks | GH downstream effects |
| Body composition | 8–12+ weeks | IGF-1 trajectory, fat oxidation cumulative |
| Skin, hair, nails | 12+ weeks | Slow tissue turnover |
The mistake users make is judging a secretagogue cycle at week 4 by body-comp criteria. Sleep is the early signal; body comp is the late one. If you don't see the sleep signal by week 3, the protocol or vial is probably the problem.
Why IGF-1 LR3 is faster but quieter
IGF-1 LR3 bypasses the GH-axis entirely and signals directly. The effects show up faster — more pump, more fullness, sometimes hypoglycemic signs after dosing — but the subjective "feel" tends to be less than people expect. It's not a euphoric compound. The lack of dramatic sensation is normal.
The "I feel nothing" reasons
If you're past the typical onset window for your peptide and feel nothing, the candidate explanations:
| Cause | Check |
|---|---|
| Bad vial | Verify vendor and COA |
| Wrong dose math | Recompute via the calculator |
| Underdosed | Some users need the high end of the range |
| Wrong target | Some injuries don't respond to BPC-157 — they need surgery, PT, or time |
| Too early | Many users want week-1 results from a 6-week compound |
| Non-responder | A minority of users genuinely don't respond to a given peptide |
The order to check: dose math, vendor, then time. Switch only after you've ruled out the first three.
What "feeling it" actually looks like (and doesn't)
Working signs:
- Pain on a known trigger movement reduces over weeks
- Sleep depth improves (especially on secretagogues)
- Recovery time between training shortens
- Mobility on a stiff joint expands
- (For IGF-1 LR3) Pump and fullness during training noticeably stronger
Not "feeling it":
- A rush during or right after injection (most peptides don't produce one)
- Detectable heart-rate or temperature change
- Anything in the first 48 hours from BPC-157 or TB-500
- A "high" of any kind
If your barometer is acute sensation, you'll be perpetually disappointed by recovery peptides. Track functional change over weeks instead.
When to extend vs stop
If you're at the late edge of the onset window:
- Sleep signal absent at week 3 on a secretagogue → check vial / dose, give 2 more weeks
- No injury improvement at week 6 on BPC-157 → check vendor, consider adding TB-500, or accept that this isn't the right tool
- No subjective change at week 8+ on any compound → stop, reassess the goal, don't extend indefinitely
Open-ended cycles "until something happens" are the wrong frame. Set a window, evaluate, decide.